Cell Biotech Co., Ltd. (KOSDAQ: 049960)
South Korea
· Delayed Price · Currency is KRW 13,670
+120 (0.89%)
Oct 11, 2024, 9:00 AM KST
Cell Biotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 93,556 | 76,789 | 86,918 | 133,300 | 166,285 | 137,400 | Upgrade
|
| Market Cap Growth | 2.35% | -11.65% | -34.80% | -19.84% | 21.02% | -34.72% | Upgrade
|
| Enterprise Value | 16,747 | 10,612 | 22,959 | 70,193 | 110,107 | 77,669 | Upgrade
|
| Last Close Price | 13670.00 | 11220.00 | 12192.90 | 17478.04 | 21265.25 | 16801.90 | Upgrade
|
| PE Ratio | 7.22 | 12.18 | 10.15 | 11.91 | 47.30 | 17.22 | Upgrade
|
| PS Ratio | 1.73 | 1.43 | 1.72 | 2.84 | 3.65 | 2.99 | Upgrade
|
| PB Ratio | 0.81 | 0.69 | 0.80 | 1.25 | 1.66 | 1.33 | Upgrade
|
| P/FCF Ratio | 5.32 | 12.26 | 8.32 | 9.49 | 25.64 | 180.03 | Upgrade
|
| P/OCF Ratio | 4.88 | 9.83 | 6.78 | 8.95 | 17.39 | 13.43 | Upgrade
|
| EV/Sales Ratio | 0.31 | 0.20 | 0.45 | 1.50 | 2.42 | 1.69 | Upgrade
|
| EV/EBITDA Ratio | 1.44 | 1.74 | 2.37 | 6.35 | 14.98 | 9.23 | Upgrade
|
| EV/EBIT Ratio | 2.18 | 4.83 | 3.79 | 9.67 | 30.02 | 13.40 | Upgrade
|
| EV/FCF Ratio | 0.95 | 1.69 | 2.20 | 5.00 | 16.98 | 101.77 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.25 | 0.10 | 0.07 | 0.18 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.08 | 0.25 | 0.09 | 0.06 | 0.21 | 1.21 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.44 | 0.43 | 0.43 | 0.42 | Upgrade
|
| Inventory Turnover | 3.54 | 3.68 | 3.34 | 3.21 | 3.44 | 4.02 | Upgrade
|
| Quick Ratio | 13.73 | 15.74 | 9.54 | 10.89 | 12.96 | 15.39 | Upgrade
|
| Current Ratio | 14.55 | 16.99 | 10.24 | 11.71 | 14.02 | 16.53 | Upgrade
|
| Return on Equity (ROE) | 11.71% | 5.73% | 7.71% | 10.05% | 3.13% | 6.91% | Upgrade
|
| Return on Assets (ROA) | 4.12% | 1.18% | 3.31% | 4.16% | 2.15% | 3.29% | Upgrade
|
| Return on Capital (ROIC) | 4.35% | 1.23% | 3.49% | 4.34% | 2.23% | 3.45% | Upgrade
|
| Earnings Yield | 13.85% | 8.21% | 9.53% | 7.79% | 1.92% | 5.26% | Upgrade
|
| FCF Yield | 18.79% | 8.16% | 12.02% | 10.54% | 3.90% | 0.56% | Upgrade
|
| Dividend Yield | 3.29% | 4.01% | 3.69% | 2.57% | 2.12% | 3.57% | Upgrade
|
| Payout Ratio | 23.75% | 48.86% | 38.43% | 30.65% | 136.11% | 62.26% | Upgrade
|
| Buyback Yield / Dilution | 0.26% | 0.73% | 2.50% | 0.32% | 4.25% | 1.26% | Upgrade
|
| Total Shareholder Return | 3.55% | 4.75% | 6.19% | 2.89% | 6.37% | 4.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.